Article

Wavefront-guided LASEK safe to enhance initial LASIK, PRK for night-vision problems

Some patients who undergo refractive procedures have a good refractive outcome but still complain of halos and starbursts at night, said Christoph Lohmann, MD, at the European Society of Cataract and Refractive Surgeons meeting.

Paris—Some patients who undergo refractive procedures have a good refractive outcome but still complain of halos and starbursts at night, said Christoph Lohmann, MD, at the European Society of Cataract and Refractive Surgeons meeting.

Dr. Lohmann, of the Universitäts-Augenklinik, Regensburg, Germany, and colleagues addressed these complaints by performing LASEK on 21 patients all of whom were within 0.5 D of emmetropia and had undergone their initial surgeries several months previously. All had been treated during the initial surgery with an older-generation laser using a small ablation zone. All LASEK re-treatments were done using the WaveLight Concept 500 excimer laser (WaveLight Laser Technologie AG) and the Allegretto Wave analyser (WaveLight Laser Technologie AG). At least a 6.5-mm optical zone was used in all cases.

All patients had a significant improvement in vision, with most patients having 20/20 or 20/15 vision or better. Even after the re-treatment, no patient lost more than one line of visual acuity.

"In all cases, we were able to reduce the visual aberrations. Eighteen of the 21 patients no longer have night-vision problems. The other three patients claim that their vision has improved substantially despite residual problems," Dr. Lohmann reported.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.